- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03911518
Loop Drainage Versus Incision and Drainage for Abscesses
Loop vs. Traditional Incision and Drainage: A Randomized Controlled Pilot Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
BACKGROUND AND SIGNIFICANCE
The usual care in the United States for abscess management is generally incision and drainage. There have been various techniques described for incision and drainage: 1. incision and drainage followed by healing by secondary intention, 2. Incision and drainage followed by primary closure, and 3. Loop drainage (more recently, the topic of this study) with subsequent loop removal and healing by secondary intention. The treatment failure rate for traditional incision and drainage is variable, but can range from 10-30%. Costs associated with treatment failure are between $1,000 and $2,0005. The relatively high failure rate associated with traditional incision and drainage has led to research into less invasive, more effective techniques. In 2010, the loop drainage technique was first described. This technique consists of making 2 small incisions on either end of the abscess cavity followed by pulling a small drain through the incisions and then tying the drain in place. It remains in place and is removed once no further drainage is noticed (usually in 10-14 days). Original studies were primarily done by pediatric surgeons using vessel loops or penrose drains.
In 2014, the concept of using the cuff from the bottom of a sterile glove was introduced. This allows for this technique to easily be used with materials found easily in any emergency department. The amount of research done with this technique on adults is limited. To date, only two studies with a total of 109 patients evaluated loop drainage in adults. One of these studies was retrospective and included only 63 patients. The other prospective study was limited in that it included only 46 patients. Given the demonstration of increased clinical cure rate in pediatric populations and the potential for increased clinical cure rates in adults, more study into this topic is worthwhile to determine the optimal approach to adult subcutaneous abscess drainage.
STUDY DESCRIPTION
This study will be a pilot study and multi-center prospective randomized controlled trial evaluating loop drainage compared to conventional incision and drainage in adults older than 18 who have simple, purulent, cutaneous abscesses deemed amenable to outpatient incision and drainage by the attending clinician.
Study participants will be randomized to investigational vs control arm in a 1:1 ratio (Randomization will occur via blocked randomization in blocks of 10). Enrollment will occur primarily when investigators are on shift (convenience sampling). This study will not be blinded, however, observer bias will be reduced by having an investigator blinded to treatment assignment determine the cosmetic healing rate at 90 days.
Participants will receive drainage of their abscess (either conventional or loop). For conventional drainage, the wound will be incised with a #11 blade scalpel along the point of maximal fluctuance, approximately 2-3 cm, and then all loculations bluntly dissected with a set of Kelly clamps. After drainage of pus, the wound will be loosely packed with gauze. Afterwards, a dry dressing will be placed and the patient will be instructed to change the external dressing twice daily or every time it becomes saturated. Patients randomized to standard care will be instructed to remove the packing at 48 hours after incision and drainage.
Loop drainage will occur via 2 small incisions, approximately 2 cm, with the cuff from the base of a sterile glove pulled through and then tied off3. The patient will be instructed to move this cuff back and forth three times daily and cover it with a dry dressing.
Once the abscess drainage procedure is complete, the participant will complete a questionnaire asking about pain during procedure and satisfaction with the procedure. All participants will be discharged with a prescription trimethoprim-sulfamethoxazole (TMP-SMX) 160mg/800mg, two tablets by mouth twice daily for ten days. All participants will be instructed to return to the emergency department and contact the PI if they have any worsening signs of infection. Between 10 and 14 days after the initial procedure, patients will follow up in the emergency department for wound recheck. At this visit, the maximal diameter of both erythema and swelling will be measured, and a questionnaire will be administered regarding wound care satisfaction, repeat medical visits, fevers, and any side effects of either the procedure or antibiotic therapy. Loop participants will have the loop removed at the follow up visit. Participants will be called at 30 days for data collection on abscess recurrences. Patient will be asked to return for a wound recheck and submit a photo of the wound, to assess cosmetic appearance of wound at 90 days.
Study Type
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults age 18 years or older
- Abscess is considered simple, purulent, and cutaneous
- Abscess is deemed amenable to outpatient drainage
Exclusion Criteria:
- Inability to speak English
- Abscess location of breast or face
- Pilonidal abscesses
- Concurrent use of chemotherapy or steroids
- Allergy to sulfa/trimethoprim or lidocaine
- Inability to provide consent
- Incarcerated patients
- Inability to give a valid contact number or email address
- Presence of multiple abscesses
- Abscess size less than 2 cm
- Pregnant patients
- History of glucose-6-phosphate dehydrogenase deficiency
- History of Steven Johnson's Syndrome
- Patients with fever greater than 100.4 Fahrenheit
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control
Incision and drainage.
|
The wound will be incised with a #11 blade scalpel along the point of maximal fluctuance, approximately 2-3 cm, and then all loculations bluntly dissected with a set of Kelly clamps.
After drainage of pus, the wound will be loosely packed with gauze.
|
Experimental: Intervention
Loop drainage.
|
Loop drainage will occur via 2 small incisions, approximately 2 cm, with the cuff from the base of a sterile glove pulled through and then tied off.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of Clinical Cure
Time Frame: Days 10-14
|
Defined as healing of the abscess without the need for further clinical intervention (change in antibiotics, repeat drainage, or admission)
|
Days 10-14
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intra-Procedure Pain Rating
Time Frame: Day 0
|
Numeric rating scale of 0-10.
A rating of 0 indicates no pain.
A rating of 10 indicates the worst pain.
|
Day 0
|
Time to Complete Drainage
Time Frame: Day 0
|
Time from initial incision to application of dry dressing
|
Day 0
|
Patient Satisfaction: Numeric rating scale
Time Frame: Days 0, 10-14
|
Likert scale of 1-5.
A rating of 1 indicates poor satisfaction.
A rating of 5 indicates the best satisfaction.
|
Days 0, 10-14
|
Provider Satisfaction: Numeric rating scale
Time Frame: Day 0
|
Likert scale of 1-5.
A rating of 1 indicates poor satisfaction.
A rating of 5 indicates the best satisfaction.
|
Day 0
|
Recurrence Rate
Time Frame: Day 30
|
New lesions requiring drainage
|
Day 30
|
Cosmetic Healing
Time Frame: Day 90
|
Visual analog scale of 1-100 mm.
A score of 1 indicates poor cosmetic healing.
A score of 100 indicates excellent cosmetic healing.
|
Day 90
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Gillian Schmitz, MD, Uniformed Services University of the Health Sciences
Publications and helpful links
General Publications
- Gottlieb M, Peksa GD. Comparison of the loop technique with incision and drainage for soft tissue abscesses: A systematic review and meta-analysis. Am J Emerg Med. 2018 Jan;36(1):128-133. doi: 10.1016/j.ajem.2017.09.007. Epub 2017 Sep 10.
- Ladde JG, Baker S, Rodgers CN, Papa L. The LOOP technique: a novel incision and drainage technique in the treatment of skin abscesses in a pediatric ED. Am J Emerg Med. 2015 Feb;33(2):271-6. doi: 10.1016/j.ajem.2014.10.014. Epub 2014 Oct 16.
- McNamara WF, Hartin CW Jr, Escobar MA, Yamout SZ, Lau ST, Lee YH. An alternative to open incision and drainage for community-acquired soft tissue abscesses in children. J Pediatr Surg. 2011 Mar;46(3):502-6. doi: 10.1016/j.jpedsurg.2010.08.019.
- Ozturan IU, Dogan NO, Karakayali O, Ozbek AE, Yilmaz S, Pekdemir M, Suner S. Comparison of loop and primary incision & drainage techniques in adult patients with cutaneous abscess: A preliminary, randomized clinical trial. Am J Emerg Med. 2017 Jun;35(6):830-834. doi: 10.1016/j.ajem.2017.01.036. Epub 2017 Jan 22.
- Thompson DO. Loop drainage of cutaneous abscesses using a modified sterile glove: a promising technique. J Emerg Med. 2014 Aug;47(2):188-91. doi: 10.1016/j.jemermed.2014.04.035. Epub 2014 Jun 11.
- Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC; Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jul 15;59(2):e10-52. doi: 10.1093/cid/ciu444. Erratum In: Clin Infect Dis. 2015 May 1;60(9):1448. Dosage error in article text.
- Gaszynski R, Punch G, Verschuer K. Loop and drain technique for subcutaneous abscess: a safe minimally invasive procedure in an adult population. ANZ J Surg. 2018 Jan;88(1-2):87-90. doi: 10.1111/ans.13709. Epub 2016 Sep 12.
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19021803
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abscess of Skin and/or Subcutaneous Tissue
-
University of Maryland, BaltimoreTerminatedAbscess of Skin and/or Subcutaneous TissueUnited States
-
Seton Healthcare FamilyScientific, Education and Research Foundation of UTSW AustinCompletedAbscess of Skin and/or Subcutaneous TissueUnited States
-
Cohera Medical, Inc.CompletedDisorder of Skin and/or Subcutaneous Tissue of TrunkUnited States
-
Federico II UniversityWithdrawnInfection of Skin and/or Subcutaneous TissueItaly
-
Endo PharmaceuticalsCompleted
-
Affinium Pharmaceuticals, LtdCompletedCellulitis | Wound Infection | Skin and Subcutaneous Tissue Bacterial Infections | Cutaneous Abscess | Burn InfectionUnited States, Canada
-
University of California, San FranciscoRecruiting
-
Rush University Medical CenterWithdrawn
-
Tufts Medical CenterCompletedCutaneous AbscessUnited States
-
University of California, San FranciscoCompleted
Clinical Trials on Incision and drainage
-
University of Massachusetts, WorcesterCompleted
-
bryan malcolmWithdrawn
-
University of Maryland, BaltimoreTerminatedAbscess of Skin and/or Subcutaneous TissueUnited States
-
Seton Healthcare FamilyScientific, Education and Research Foundation of UTSW AustinCompletedAbscess of Skin and/or Subcutaneous TissueUnited States
-
Samsun Education and Research HospitalCompletedIdiopathic Granulomatous MastitisTurkey
-
Kocaeli UniversityCompleted
-
University of Massachusetts, WorcesterBeth Israel Deaconess Medical CenterCompletedAbscess | CellulitisUnited States
-
Boston Medical CenterCompletedCutaneous AbscessUnited States
-
Nantes University HospitalActive, not recruitingBartholin's Gland Abscess TreatmentFrance